Vahaticor
Santa Clara, US · Founded 2021 · 2 known investors
VahatiCor develops the A-FLUX Reducer System, a self-expanding nitinol mesh implant placed in the coronary sinus to improve microvascular perfusion in patients with symptomatic coronary microvascular dysfunction (CMD). The device targets patients who experience chest pain despite normal angiograms.
Founders & leadership
MB
Marwan Berrada-SounniExecutive Officer, Director
HR
Harry RowlandChief Executive Officer
KV
Kevin Van BladelChief Technology Officer
MN
Mark NiggliChief Commercial Officer
BR
Brian R. SmithDirector
DS
Daniel SheehanDirector
JC
Jerrett CreedDirector
BS
Bruce SamuelsDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$21.2MraisedDec 2025 · 19 investors · Other Health CareRule 506(b)
▶$21.2MraisedDec 2025 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian R. SmithDirector
- Marwan Berrada-SounniExecutive Officer, Director
- Daniel SheehanDirector
- Jerrett CreedDirector
- Bruce SamuelsDirector
- Offering amount
- $32.4M
- Amount sold
- $21.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.